|
|
ProAuctum is very pleased to announce a January 2025 increase in fund value of +3.7% which exceeded the return on the index of +2.0%.
ProAuctum's,
ASX 100 Fund latest portfolio composition and monthly result to date
is displayed below
February 2025 Portfolio Performance to Date: (from 28-Jan-25 ) |
Stock |
Weight |
Initial Price |
Last price |
Increase |
Name |
PME |
35.10% |
272.15 |
288.90 |
6.15% |
Pro Medicus Ltd |
PNI |
28.10% |
25.45 |
26.04 |
2.32% |
Pinnacle Investment Management |
TLX |
27.60% |
28.29 |
29.15 |
3.04% |
TELIX Pharmaceuticals |
TNE |
9.20% |
30.03 |
31.80 |
5.89% |
Technology One |
ProAuctum |
100.00% |
100.00 |
104.19 |
4.19% |
at 7:03 AM |
ASX 100 |
100.00% |
7087.00 |
8780.00 |
23.89% |
|
Price retrieval fail: the following prices are not current: ( PME PNI TLX TNE ) Sunday, February 9, 2025 |
ProAuctum Performance Record |
Measure |
ProAuctum |
ASX 100 |
1-Year |
36.2%pa |
10.3%pa |
2-Year |
12.6%pa |
5.8%pa |
5-Year |
6.6%pa |
4.0%pa |
Max period 19-years |
16.1%pa |
2.9%pa |
Monthly record |
ProAuctum |
ASX 100 |
Jan-25 |
3.71% |
1.97% |
Dec-24 |
-5.33% |
-2.13% |
Nov-24 |
-1.13% |
3.09% |
Oct-24 |
3.92% |
-0.19% |
Sep-24 |
10.64% |
2.80% |
Aug-24 |
-3.60% |
-1.30% |
Jul-24 |
4.13% |
4.49% |
Jun-24 |
13.90% |
-0.08% |
May-24 |
3.88% |
2.53% |
Apr-24 |
3.84% |
-3.02% |
Mar-24 |
-3.70% |
-0.41% |
Feb-24 |
2.14% |
2.16% |
|
|
|
|
Visits updated
lblConn0
|
|